Free CPD Course   |  April & May |  With Ceva Animal Health
Course Summary
Feline hypertension is common, under-recognised, and often silent until we see target organ damage. In this course, we'll take you through a practical, step-by-step approach highlighting when and how to measure blood pressure, how to interpret your findings, and how to build monitoring into routine senior cat care.
We’ll look at hypertension in the context of chronic kidney disease, hyperthyroidism and other concurrent conditions, and explore how to manage these as separate, but closely linked problems.Â
We'll also review the evidence behind first-line antihypertensive choices, and how to explain treatment plans clearly to owners.Â
 Join us on this course to build your confidence with feline hypertension and help your patients avoid preventable target organ damage, while maintaining a good quality of life.Â
What You'll Learn
Sign Up Now!
Complete the form below to register for this FREE course.
*By ticking this box, you agree to receive email communications from Ceva Animal Health about our new e-newsletter, Inside the Consult, including hot clinical topics, new innovations, and free CPD opportunities for vets and nurses. You can unsubscribe at any time. Your data will be processed in accordance with applicable data protection legislation and Ceva’s Privacy Policy.
Feline Hypertension Management Course Overview
|
1 |
What is Feline Hypertension? |
Explains the prevalence, silent nature, and clinical importance of routinely measuring blood pressure in ageing and at‑risk cats. |
|
2 |
CKD & Feline Hypertension Part 1 |
Describes how CKD increases hypertension risk and the renal damage caused when blood pressure overwhelms autoregulation. |
|
3 |
CKD & Feline Hypertension Part 2 |
Outlines how amlodipine effectively treats hypertension across CKD stages, how to monitor and titrate dosing, and how BP control reduces proteinuria. |
|
4 |
Case Study |
Follows a real feline case example with CKD and hypertension to offer practical guidance on diagnosis, treatment, monitoring, and sequencing of clinical decisions. |
|
5 |
Hypertension & Hyperthyroidism |
Explores the interrelationship between hyperthyroidism and hypertension, the importance of measuring blood pressure at diagnosis but also after stabilisation of hyperthyroidism, and how to effectively manage patients where both conditions occur concurrently. |
|
6 |
Other Concurrent Disease |
Reviews  less common causes of hypertension, particularly in relation to adrenal disorders, outlining appropriate diagnostic and treatment approaches. |
|
7 |
Summary |
Reinforces the importance of routine screening, early diagnosis, structured monitoring, and amlodipine as a reliable first‑line therapy. |
|
8 |
Why Amlodipine? |
Summarises why guidelines recommend amlodipine as the first-choice therapy for feline hypertension and introduces Amodip® as a palatable, cat‑specific formulation supporting accurate and effective treatment. |
| Â | Â | Â |
Meet The Speaker
Professor Rosanne Jepson
BVSc MVetMed PhD DipACVIM DipECVIM PGCertVetEd FHEA FRCVS
Rosanne is Professor of Small Animal Internal Medicine and Nephrology, recognised RCVS, ACVIM, ECVIM Specialist in Small Animal Internal Medicine and a founding member of the American Colllege of Veterinary Nephrology and Urology.
Her particular areas of interest include canine and feline nephrology and urology and systemic hypertension. She is a member of the RVC GFR Service, co-director of the QMHA renal replacement unit and is one of two clinicians offering minimally invasive urological procedures including laser lithotripsy and laser ablation of ectopic ureters at the Queen Mother Hospital for Animals (QMHA).
She has an active research profile in feline and canine renal disease and hypertension with an extensive publication record both in peer reviewed journals and as author of numerous textbook chapters.
As well as lecturing both nationally and internationally, Rosanne is involved in both undergraduate and postgraduate (Royal Veterinary College CertAVP Medicine Module leader and ACVIM/ECVIM residency training) level education. She is also Head of the Infection Protection and Control Committee at the QMHA.
Watch in April to be entered into a prize draw for ÂŁ250!
This course will be available for a limited time, until the end of May 2026.
However, please note that the survey and prize draw are only open to viewers who complete the course during April.
As part of the challenge, anyone who watches the course and enters the competition before 23:59 on 30th April will be automatically entered into a prize draw to win ÂŁ250. For more information contact your Ceva Territory Manager.
Competition open to UK vets and nurses only; however the course can be accessed by veterinary professionals in any location.
ENTER HERE
Ceva Animal Health
Ceva Animal Health Ltd is the UK subsidiary of the Ceva Group, launched in the UK in 2000 and based in Wooburn Green, Buckinghamshire. For cats and dogs, Ceva’s portfolio includes ADAPTIL® (dogs) and FELIWAY® (cats) for pet behaviour support, and the cardiology product Cardalis®, a fixed-dose combination of benazepril (ACE inhibitor) and spironolactone, indicated for congestive heart failure caused by chronic degenerative valvular disease in dogs (with diuretic support as appropriate). Ceva also provides Amodip® 1.25 mg chewable tablets for cats, containing amlodipine and indicated for the treatment of systemic hypertension in cats. In dermatology, Ceva’s DOUXO® S3 range is positioned as targeted support for pet skin issues and is presented as developed by pet dermatology experts and trusted by vets.
Learn more